Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse J Smith

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Vascular Surgery|February 26, 2004
Cold visceral perfusion improves early survival in patients with acute renal failure after thoracoabdominal aortic aneurysm repairHeitham T Hassoun, Charles C Miller, Tam T T Huynh, et al.
Carcinogenesis|April 29, 2015
ERBB4 is over-expressed in human colon cancer and enhances cellular transformationChristopher S Williams, Jessica K Bernard, Michelle Demory Beckler, et al.
Trends in Pharmacological Sciences|March 25, 2022
Reprogramming RNA processing: an emerging therapeutic landscapeChristopher R Neil, Michael W Seiler, Dominic J Reynolds, et al.
Molecular and Cellular Biology|December 24, 2008
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytesTakeshi Yoshizaki, Jill C Milne, Takeshi Imamura, et al.
FEBS Letters|August 2, 2012
A687V EZH2 is a gain-of-function mutation found in lymphoma patientsChristina R Majer, Lei Jin, Margaret Porter Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 5, 2014
DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cellsChristine R Klaus, Dorothy Iwanowicz, Danielle Johnston, et al.
Journal of Biomolecular Screening|May 14, 2004
Multiplex GPCR assay in reverse transfection cell microarraysYuji M Mishina, Christopher J Wilson, Linda Bruett, et al.
ACS Chemical Biology|August 26, 2014
Reaction coupling between wild-type and disease-associated mutant EZH2Brooke M Swalm, Sarah K Knutson, Natalie M Warholic, et al.
Diseases of the Colon and Rectum|January 17, 2023
Comparison of Robotic, Laparoscopic, and Open Resections of Nonmetastatic Colon CancerJonathan B Yuval, Hannah M Thompson, Floris S Verheij, et al.
Molecular Cancer Therapeutics|March 16, 2017
Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: <i>In Vitro</i> and <i>In Vivo</i> Preclinical ModelsElayne Chan-Penebre, Kelli Armstrong, Allison Drew, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Vascular Surgery|February 26, 2004
Cold visceral perfusion improves early survival in patients with acute renal failure after thoracoabdominal aortic aneurysm repairHeitham T Hassoun, Charles C Miller, Tam T T Huynh, et al.
Carcinogenesis|April 29, 2015
ERBB4 is over-expressed in human colon cancer and enhances cellular transformationChristopher S Williams, Jessica K Bernard, Michelle Demory Beckler, et al.
Trends in Pharmacological Sciences|March 25, 2022
Reprogramming RNA processing: an emerging therapeutic landscapeChristopher R Neil, Michael W Seiler, Dominic J Reynolds, et al.
Molecular and Cellular Biology|December 24, 2008
SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytesTakeshi Yoshizaki, Jill C Milne, Takeshi Imamura, et al.
FEBS Letters|August 2, 2012
A687V EZH2 is a gain-of-function mutation found in lymphoma patientsChristina R Majer, Lei Jin, Margaret Porter Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 5, 2014
DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cellsChristine R Klaus, Dorothy Iwanowicz, Danielle Johnston, et al.
Journal of Biomolecular Screening|May 14, 2004
Multiplex GPCR assay in reverse transfection cell microarraysYuji M Mishina, Christopher J Wilson, Linda Bruett, et al.
ACS Chemical Biology|August 26, 2014
Reaction coupling between wild-type and disease-associated mutant EZH2Brooke M Swalm, Sarah K Knutson, Natalie M Warholic, et al.
Diseases of the Colon and Rectum|January 17, 2023
Comparison of Robotic, Laparoscopic, and Open Resections of Nonmetastatic Colon CancerJonathan B Yuval, Hannah M Thompson, Floris S Verheij, et al.
Molecular Cancer Therapeutics|March 16, 2017
Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: <i>In Vitro</i> and <i>In Vivo</i> Preclinical ModelsElayne Chan-Penebre, Kelli Armstrong, Allison Drew, et al.
Pageof 4